Mecviz Endoscopy (I) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -99.52%
(FY 2023)
- Profit -99.89%
(FY 2023)
- Ebitda -103.82%
(FY 2023)
- Net Worth 0.11%
(FY 2023)
- Total Assets -6.85%
(FY 2023)
About Mecviz Endoscopy (I)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chetan Joshi and Saurabh Bhatt serve as directors at the Company.
- CIN/LLPIN
U33110GJ2012PTC069910
- Company No.
069910
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mecviz Endoscopy (I) Private Limited offer?
Mecviz Endoscopy (I) Private Limited offers a wide range of products and services, including VFD, PLC, HMI & Control Equipments, PLC, CCTV Camera, IP Camera, Interior Designers, 3D Interior Rendering, Forceps & Graspers, Laparoscopic Instruments.
Who are the key members and board of directors at Mecviz Endoscopy (I)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Bhatt  | Director | 17-Apr-2012 | Current |
| Chetan Joshi | Director | 17-Apr-2012 | Current |
Financial Performance and Corporate Structure Insights of Mecviz Endoscopy (I).
Mecviz Endoscopy (I) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.52% decrease. The company also saw a substantial fall in profitability, with a 99.89% decrease in profit. The company's net worth moved up by a moderate rise of 0.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mecviz Endoscopy (I)?
In 2023, Mecviz Endoscopy (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aprameya Engineering (India) Private LimitedActive 14 years 6 months
Chetan Joshi and Saurabh Bhatt are mutual person
- Aprameya Engineering LimitedActive 2 years 11 months
Chetan Joshi and Saurabh Bhatt are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mecviz Endoscopy (I)?
Unlock and access historical data on people associated with Mecviz Endoscopy (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mecviz Endoscopy (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mecviz Endoscopy (I)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
